Jared D Acoba
University of Hawaii · University of Hawaii Cancer Research Center
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Jared D Acoba as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-11 23:51 UTC. Open this list on ClinicalTrials.gov
- Ph1NCT07075120 · Ipilimumab and Nivolumab With SBRT in Locally Advanced Hepatocellular CancerUniversity of Hawaii · recruiting · Hepatocellular Carcinoma (HCC) · principal investigator
- Ph2NCT03680508 · TSR-022 (Anti-TIM-3 Antibody) and TSR-042 (Anti-PD-1 Antibody) in Patients With Liver CancerUniversity of Hawaii · active not recruiting · Adult Primary Liver Cancer, Advanced Adult Primary Liver Cancer, Localized Unresectable Adult Primary Liver Cancer · principal investigator
- Ph2NCT01524575 · Gemcitabine and Oxaliplatin in the Management of Metastatic Pancreatic Cancers With Low Expression of ERCC1University of Hawaii · withdrawn · Metastatic Pancreatic Cancer, ERCC1 · principal investigator
Grants
NIH projects from RePORTER, fetched 2026-11-11 23:51 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.
- The Hawaii NCORPUG1CA189804 · NCI · UNIVERSITY OF HAWAII AT MANOA · fiscal years 2019 to 2026 · $1,486,270 awarded in 2026Same name and institution; not confirmed by an ID
Most cited trial papers
Clinical-trial papers with this author name, ranked by citations from NIH iCite, fetched 2026-11-11 23:51 UTC. The ranking covers the 200 most relevant of 1 PubMed records, and a shared surname and initials can bring in a namesake. All 1 on PubMed